BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 29105334)

  • 21. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.
    van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic determinants of uveal melanoma.
    Couturier J; Saule S
    Dev Ophthalmol; 2012; 49():150-165. PubMed ID: 22042019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uveal melanoma: Towards a molecular understanding.
    Smit KN; Jager MJ; de Klein A; Kiliҫ E
    Prog Retin Eye Res; 2020 Mar; 75():100800. PubMed ID: 31563544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uveal melanoma hepatic metastases mutation spectrum analysis using targeted next-generation sequencing of 400 cancer genes.
    Luscan A; Just PA; Briand A; Burin des Roziers C; Goussard P; Nitschké P; Vidaud M; Avril MF; Terris B; Pasmant E
    Br J Ophthalmol; 2015 Apr; 99(4):437-9. PubMed ID: 25361747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic disease in uveal melanoma: importance of a genetic profile?
    Van Beek JG; Koopmans AE; Vaarwater J; Verdijk RM; de Klein A; Naus NC; Kiliç E
    Melanoma Res; 2015 Oct; 25(5):447-9. PubMed ID: 26086698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma.
    de Lange MJ; van Pelt SI; Versluis M; Jordanova ES; Kroes WG; Ruivenkamp C; van der Burg SH; Luyten GP; van Hall T; Jager MJ; van der Velden PA
    Oncotarget; 2015 Nov; 6(35):37824-35. PubMed ID: 26462151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of extraocular extension in relation to monosomy 3 and gain of chromosome 8q in uveal melanoma.
    van Beek JG; Koopmans AE; Vaarwater J; de Rooi JJ; Paridaens D; Naus NC; de Klein A; Verdijk RM; Kiliç E
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1284-91. PubMed ID: 24508790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study.
    Thomas S; Pütter C; Weber S; Bornfeld N; Lohmann DR; Zeschnigk M
    Br J Cancer; 2012 Mar; 106(6):1171-6. PubMed ID: 22353812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4.
    Johansson P; Aoude LG; Wadt K; Glasson WJ; Warrier SK; Hewitt AW; Kiilgaard JF; Heegaard S; Isaacs T; Franchina M; Ingvar C; Vermeulen T; Whitehead KJ; Schmidt CW; Palmer JM; Symmons J; Gerdes AM; Jönsson G; Hayward NK
    Oncotarget; 2016 Jan; 7(4):4624-31. PubMed ID: 26683228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic, prognostic, and cell-signaling advances in uveal melanoma.
    Harbour JW
    Am Soc Clin Oncol Educ Book; 2013; ():388-91. PubMed ID: 23714557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma.
    Cassoux N; Rodrigues MJ; Plancher C; Asselain B; Levy-Gabriel C; Lumbroso-Le Rouic L; Piperno-Neumann S; Dendale R; Sastre X; Desjardins L; Couturier J
    Br J Ophthalmol; 2014 Jun; 98(6):769-74. PubMed ID: 24169649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uveal melanoma prognostication: from lesion size and cell type to molecular class.
    Gill HS; Char DH
    Can J Ophthalmol; 2012 Jun; 47(3):246-53. PubMed ID: 22687301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [DEVELOPMENT AND CHALLENGES IN TREATMENT OF UVEAL MELANOMA].
    Zloto O; Vishnevskia-Dai V; Moisseiev J; Fabian ID
    Harefuah; 2018 Feb; 157(2):95-98. PubMed ID: 29484864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 8q Gain Has No Additional Predictive Value in
    Nguyen JQN; Drabarek W; Vaarwater J; Yavuzyigitoglu S; Verdijk RM; Paridaens D; Naus NC; de Klein A; Brosens E; Kiliç E;
    Ophthalmol Sci; 2024; 4(2):100413. PubMed ID: 38187129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort.
    Lamas NJ; Lassalle S; Martel A; Nahon-Estève S; Macocco A; Zahaf K; Lalvee S; Fayada J; Lespinet-Fabre V; Bordone O; Pedeutour F; Baillif S; Hofman P
    Pathology; 2023 Dec; 55(7):929-944. PubMed ID: 37863710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours.
    Johansson PA; Brooks K; Newell F; Palmer JM; Wilmott JS; Pritchard AL; Broit N; Wood S; Carlino MS; Leonard C; Koufariotis LT; Nathan V; Beasley AB; Howlie M; Dawson R; Rizos H; Schmidt CW; Long GV; Hamilton H; Kiilgaard JF; Isaacs T; Gray ES; Rolfe OJ; Park JJ; Stark A; Mann GJ; Scolyer RA; Pearson JV; van Baren N; Waddell N; Wadt KW; McGrath LA; Warrier SK; Glasson W; Hayward NK
    Nat Commun; 2020 May; 11(1):2408. PubMed ID: 32415113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma.
    Lake SL; Kalirai H; Dopierala J; Damato BE; Coupland SE
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2647-52. PubMed ID: 22427594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of plaque brachytherapy and proton beam radiotherapy on prognostic testing: a comparison of uveal melanoma genotyped by microsatellite analysis.
    Thornton S; Coupland SE; Heimann H; Hussain R; Groenewald C; Kacperek A; Damato B; Taktak A; Eleuteri A; Kalirai H
    Br J Ophthalmol; 2020 Oct; 104(10):1462-1466. PubMed ID: 32024655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
    Schefler AC; Koca E; Bernicker EH; Correa ZM
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic findings in treatment-naïve and proton-beam-radiated iris melanomas.
    Krishna Y; Kalirai H; Thornton S; Damato BE; Heimann H; Coupland SE
    Br J Ophthalmol; 2016 Jul; 100(7):1012-1016. PubMed ID: 27098748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.